WHO's Science in 5 on COVID-19: vaccines, variants & herd immunity
Date:
26/02/2021
As new variants emerge people are wondering if they should wait until a more efficacious vaccine is available or if they should go ahead and get vaccinated now? Answering your questions on COVID-19 vaccines and variants in this episode of Science in 5 is WHO's Dr Soumya Swaminathan.
See more details
Betacoronavirus/immunology, Coronavirus Infections/immunology, Pneumonia, Viral/immunology, Pandemics/prevention & control, Health Communication, Viral Vaccines/immunology, Mutation/genetics, Betacoronavirus/genetics, Coronavirus Infections/genetics, Pneumonia, Viral/genetics, COVID-19, Covax
Safety of COVID-19 vaccines: what we need to know
Date:
19/02/2021
As the world rolls out COVID-19 vaccines, many people are asking what to expect – in particular, are these vaccines safe? The answer is yes, but here’s a bit more information you may find useful.
See more details
Betacoronavirus/immunology, Coronavirus Infections/immunology, Pneumonia, Viral/immunology, Pandemics/prevention & control, Health Communication, Viral Vaccines/immunology, COVID-19
WHO’s Science in 5 on COVID-19: vaccine dosage
Date:
19/02/2021
How far apart should the doses of vaccines be? What if I miss my second dose? Can I get two doses from two different manufacturers? How was safety of vaccines ensured?
See more details
Betacoronavirus/immunology, Coronavirus Infections/immunology, Pneumonia, Viral/immunology, Pandemics/prevention & control, Health Communication, Immunization Programs/organization & administration, Viral Vaccines/administration & dosage, Dose-Response Relationship, Immunologic, COVID-19
Follow the journey of a vaccine
Date:
04/02/2021
From clinic trials and emergency use listing to production, transportation, storage and final administration by local health workers – follow the journey of a vaccine.
See more details
Betacoronavirus/immunology, Coronavirus Infections/immunology, Pneumonia, Viral/immunology, Pandemics/prevention & control, Health Communication, Viral Vaccines/standards, COVID-19
Here is how Pfizer/BioNTech COVID-19 vaccine should be used
Date:
03/02/2021
The Pfizer/BioNTech COVID-19 vaccine is the first vaccine to receive WHO validation for emergency use. Here is how it should be used.
See more details
Betacoronavirus/immunology, Coronavirus Infections/immunology, Pneumonia, Viral/immunology, Pandemics/prevention & control, Health Communication, Immunization Programs/organization & administration, Viral Vaccines/supply & distribution, COVID-19, Pfizer, BioNTech
The road to a COVID-19 vaccine
Date:
01/02/2021
Developing a vaccine is a long road full of checkpoints. Each phase designed to make sure it is both effective and safe. But with the whole world struggling to contain a pandemic, and unprecedented amounts of funding available, the road to finding the COVID-19 vaccine looks more like this.
See more details
Betacoronavirus/immunology, Coronavirus Infections/immunology, Pneumonia, Viral/immunology, Pandemics/prevention & control, Health Communication, Immunization Programs/organization & administration, Viral Vaccines/supply & distribution, COVID-19
COVID-19 live Q&A about vaccines, diagnostics & therapeutics safety. Ask WHO of 20 January 2021
Date:
20/01/2021
#AskWHO series: This was the live discussion of 20 January 2021 about the COVID-19 vaccines, diagnostics and therapeutics safety assessment and approvals for use.
See more details
Betacoronavirus/immunology, Coronavirus Infections/immunology, Pneumonia, Viral/immunology, Pandemics/prevention & control, Health Communication, Viral Vaccines/immunology, Therapies, Investigational, Epidemiological Monitoring, COVID-19
COVID-19 vaccines live Q&A with Dra Kate L. O´Brien and Dr Alejandro Cravioto. Ask WHO of 7 Jan. 2021
Date:
07/01/2021
AskWHO series: This was the live discussion about the COVID-19 pandemic of 7 January 2021 with Dr Alejandro Cravioto, Chair of the WHO Strategic Advisory Experts Group on Immunization and Dr Katherine O’Brien, Head of WHO Immunization, Vaccines and Biologicals department answer questions about COVID-19 vaccines from the general public.
See more details
Betacoronavirus/immunology, Coronavirus Infections/immunology, Pneumonia, Viral/immunology, Pandemics/prevention & control, Health Communication, Clinical Trial Protocol, Viral Vaccines/immunology, Dose-Response Relationship, Immunologic, Viral Vaccines/adverse effects, Viral Vaccines/supply & distribution, Access to Essential Medicines and Health Technologies, COVID-19
Getting vaccines, medicines and tests ready for emergency use
Date:
21/12/2020
Making vaccines, tests and medicines available can take a long time, even when there’s a health emergency like COVID -19. To ensure rapid access for all, the World Health Organization has developed the Emergency Use Listing - EUL - and this video explains how EUL works.
See more details
Coronavirus Infections/prevention & control, Pneumonia, Viral/prevention & control, Pandemics/prevention & control, Access to Essential Medicines and Health Technologies, Health Communication, COVID-19
How COVID-19 vaccines are able to be developed so fast?
Date:
07/12/2020
WHO Chief Scientis, Dr Soumya Swaminathan, explains why COVID-19 vaccines are able to be developed so fast.
See more details
Betacoronavirus/immunology, Coronavirus Infections/immunology, Pneumonia, Viral/immunology, Pandemics/prevention & control, Health Communication, Viral Vaccines/immunology, COVID-19